LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Search

Repligen Corp

Suletud

SektorTervishoid

124.55 -1.64

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

124.13

Max

125.75

Põhinäitajad

By Trading Economics

Sissetulek

9M

15M

Müük

13M

182M

P/E

Sektori keskmine

466.89

34.427

Kasumimarginaal

8.152

Töötajad

1,778

EBITDA

7.7M

44M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+42.49% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

11. nov 2025

Turustatistika

By TradingEconomics

Turukapital

-428M

6.3B

Eelmine avamishind

126.19

Eelmine sulgemishind

124.55

Uudiste sentiment

By Acuity

55%

45%

305 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Repligen Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. aug 2025, 16:11 UTC

Suurimad hinnamuutused turgudel

Health Insurers Climb as Berkshire Hathaway Takes UnitedHealth Stake

15. aug 2025, 22:22 UTC

Market Talk

Global Equities Roundup: Market Talk

15. aug 2025, 22:22 UTC

Market Talk

Target Is Falling Behind Its Peers -- Market Talk

15. aug 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. aug 2025, 20:33 UTC

Market Talk

U.S. Treasury Yields Close the Week Little Changed -- Market Talk

15. aug 2025, 20:25 UTC

Tulu
Omandamised, ülevõtmised, äriostud

This Meatpacker Stock Is a Quality Buy at a Discount Price -- Barrons.com

15. aug 2025, 20:24 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15. aug 2025, 20:18 UTC

Tulu

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15. aug 2025, 19:14 UTC

Market Talk

U.S. Natural Gas Settles Higher, But Down on Week -- Market Talk

15. aug 2025, 19:12 UTC

Market Talk

Oil Futures Settle Lower Ahead of U.S.-Russia Summit -- Market Talk

15. aug 2025, 18:32 UTC

Market Talk

Coffee Futures Surge on New Brazilian Frost -- Market Talk

15. aug 2025, 17:33 UTC

Market Talk

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

15. aug 2025, 17:23 UTC

Market Talk
Tulu

Deere's Earnings Appear to Be Troughing -- Market Talk

15. aug 2025, 16:27 UTC

Tulu

Tariffs Have Rocked e.l.f. Beauty Shares. Why the Fundamentals Still Look Alluring. -- Barrons.com

15. aug 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. aug 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

15. aug 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

15. aug 2025, 16:05 UTC

Omandamised, ülevõtmised, äriostud

Intel's Move Toward Nationalization Won't Work -- at Least for the Long Haul -- Heard on the Street -- WSJ

15. aug 2025, 15:52 UTC

Omandamised, ülevõtmised, äriostud

What Applied Materials' Poor Outlook Means for Chip Stocks -- Barrons.com

15. aug 2025, 15:36 UTC

Market Talk

Base Metal Prices Mixed; Copper Gains as Focus Shifts to Fundamentals -- Market Talk

15. aug 2025, 15:29 UTC

Tulu

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

15. aug 2025, 15:29 UTC

Omandamised, ülevõtmised, äriostud

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

15. aug 2025, 15:28 UTC

Tulu

JD.com Stock Rises After Earnings Beat. Why Investors Are Relieved. -- Barrons.com

15. aug 2025, 15:24 UTC

Market Talk

Gold Futures Tick Higher But Remain Broadly Rangebound -- Market Talk

15. aug 2025, 15:08 UTC

Market Talk

Applied Materials Is Losing Share in Chips Business -- Market Talk

15. aug 2025, 14:38 UTC

Omandamised, ülevõtmised, äriostud

African Rainbow Minerals to Own 19.9% of Surge Copper Shares

15. aug 2025, 14:37 UTC

Omandamised, ülevõtmised, äriostud

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares for C$4.51M

15. aug 2025, 14:37 UTC

Omandamised, ülevõtmised, äriostud

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares at C$0.175 Each

15. aug 2025, 14:36 UTC

Omandamised, ülevõtmised, äriostud

African Rainbow Minerals to Acquire Shares of Surge Copper Corp.

15. aug 2025, 14:33 UTC

Omandamised, ülevõtmised, äriostud

A Trump Intel Stake Could Make National Security the New 'Too Big to Fail' -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Repligen Corp Prognoos

Hinnasiht

By TipRanks

42.49% tõus

12 kuu keskmine prognoos

Keskmine 177.17 USD  42.49%

Kõrge 220 USD

Madal 126 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Repligen Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

10

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

125.31 / 140.7Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Sentiment

By Acuity

305 / 374 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.